关于瞬时受体电位香草酸亚型1（TRPV1）拮抗作用的体温调节风险 - Suppr

Suppr

超能文献

On the thermoregulatory perils of TRPV1 antagonism.

作者信息

Caterina Michael J

出版信息

Pain. 2008 May;136(1-2):3-4. doi: 10.1016/j.pain.2008.02.033. Epub 2008 Mar 24.

DOI:10.1016/j.pain.2008.02.033

PMID:18359567

Abstract

摘要

相似文献

On the thermoregulatory perils of TRPV1 antagonism.

Pain. 2008 May;136(1-2):3-4. doi: 10.1016/j.pain.2008.02.033. Epub 2008 Mar 24.

Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans.

Pain. 2008 May;136(1-2):202-10. doi: 10.1016/j.pain.2008.01.024. Epub 2008 Mar 11.

Answering the burning question of how transient receptor potential vanilloid-1 channel antagonists cause unwanted hyperthermia.

Pharmacol Rev. 2009 Sep;61(3):225-7. doi: 10.1124/pr.109.001875.

TRPV1 antagonists: clinical setbacks and prospects for future development.

Prog Med Chem. 2012;51:57-70. doi: 10.1016/B978-0-12-396493-9.00002-9.

Thermoregulation: channels that are cool to the core.

Curr Biol. 2007 Oct 23;17(20):R885-7. doi: 10.1016/j.cub.2007.08.016.

Substituted aryl pyrimidines as potent and soluble TRPV1 antagonists.

Bioorg Med Chem Lett. 2008 Sep 15;18(18):5118-22. doi: 10.1016/j.bmcl.2008.07.112. Epub 2008 Jul 31.

Trisubstituted pyrimidines as transient receptor potential vanilloid 1 (TRPV1) antagonists with improved solubility.

Bioorg Med Chem Lett. 2007 Dec 1;17(23):6539-45. doi: 10.1016/j.bmcl.2007.09.080. Epub 2007 Oct 15.

Effects of the transient receptor potential vanilloid 1 antagonist A-425619 on body temperature and thermoregulation in the rat.

Neuroscience. 2008 Sep 22;156(1):165-74. doi: 10.1016/j.neuroscience.2008.06.069. Epub 2008 Jul 25.

Analgesic potential of TRPV1 antagonists.

Biochem Pharmacol. 2009 Aug 1;78(3):211-6. doi: 10.1016/j.bcp.2009.02.014. Epub 2009 Mar 5.

The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation.

J Neurosci. 2007 Mar 28;27(13):3366-74. doi: 10.1523/JNEUROSCI.4833-06.2007.

引用本文的文献

A journey from molecule to physiology and tools for drug discovery targeting the transient receptor potential vanilloid type 1 (TRPV1) channel.

Front Pharmacol. 2024 Jan 24;14:1251061. doi: 10.3389/fphar.2023.1251061. eCollection 2023.

[Pain measurement in animal models].

Z Rheumatol. 2013 Mar;72(2):163-5. doi: 10.1007/s00393-013-1147-4.

Gene therapy for pain: results of a phase I clinical trial.

Ann Neurol. 2011 Aug;70(2):207-12. doi: 10.1002/ana.22446. Epub 2011 Jul 27.

Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system.

Pharmacol Ther. 2011 Jul;131(1):142-70. doi: 10.1016/j.pharmthera.2011.03.006. Epub 2011 Mar 21.

The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor.

Br J Pharmacol. 2008 Dec;155(8):1145-62. doi: 10.1038/bjp.2008.351. Epub 2008 Sep 22.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

On the thermoregulatory perils of TRPV1 antagonism.

Pain. 2008 May;136(1-2):3-4. doi: 10.1016/j.pain.2008.02.033. Epub 2008 Mar 24.

Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans.

Pain. 2008 May;136(1-2):202-10. doi: 10.1016/j.pain.2008.01.024. Epub 2008 Mar 11.

Answering the burning question of how transient receptor potential vanilloid-1 channel antagonists cause unwanted hyperthermia.

Pharmacol Rev. 2009 Sep;61(3):225-7. doi: 10.1124/pr.109.001875.

TRPV1 antagonists: clinical setbacks and prospects for future development.

Prog Med Chem. 2012;51:57-70. doi: 10.1016/B978-0-12-396493-9.00002-9.

Thermoregulation: channels that are cool to the core.

Curr Biol. 2007 Oct 23;17(20):R885-7. doi: 10.1016/j.cub.2007.08.016.

Substituted aryl pyrimidines as potent and soluble TRPV1 antagonists.

Bioorg Med Chem Lett. 2008 Sep 15;18(18):5118-22. doi: 10.1016/j.bmcl.2008.07.112. Epub 2008 Jul 31.

Trisubstituted pyrimidines as transient receptor potential vanilloid 1 (TRPV1) antagonists with improved solubility.

Bioorg Med Chem Lett. 2007 Dec 1;17(23):6539-45. doi: 10.1016/j.bmcl.2007.09.080. Epub 2007 Oct 15.

Effects of the transient receptor potential vanilloid 1 antagonist A-425619 on body temperature and thermoregulation in the rat.

Neuroscience. 2008 Sep 22;156(1):165-74. doi: 10.1016/j.neuroscience.2008.06.069. Epub 2008 Jul 25.

Analgesic potential of TRPV1 antagonists.

Biochem Pharmacol. 2009 Aug 1;78(3):211-6. doi: 10.1016/j.bcp.2009.02.014. Epub 2009 Mar 5.

The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation.

J Neurosci. 2007 Mar 28;27(13):3366-74. doi: 10.1523/JNEUROSCI.4833-06.2007.

引用本文的文献

A journey from molecule to physiology and tools for drug discovery targeting the transient receptor potential vanilloid type 1 (TRPV1) channel.

Front Pharmacol. 2024 Jan 24;14:1251061. doi: 10.3389/fphar.2023.1251061. eCollection 2023.

[Pain measurement in animal models].

Z Rheumatol. 2013 Mar;72(2):163-5. doi: 10.1007/s00393-013-1147-4.

Gene therapy for pain: results of a phase I clinical trial.

Ann Neurol. 2011 Aug;70(2):207-12. doi: 10.1002/ana.22446. Epub 2011 Jul 27.

Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system.

Pharmacol Ther. 2011 Jul;131(1):142-70. doi: 10.1016/j.pharmthera.2011.03.006. Epub 2011 Mar 21.

The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor.

Br J Pharmacol. 2008 Dec;155(8):1145-62. doi: 10.1038/bjp.2008.351. Epub 2008 Sep 22.